ArticleCancer management and research2018

Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma.

Xinping Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.